• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前经颈静脉肝内门体分流术对失代偿期肝硬化患者非移植手术后术后结局的影响。

Impact of pre-operative transjugular intrahepatic portosystemic shunt on post-operative outcomes following non-transplant surgeries in patients with decompensated cirrhosis.

作者信息

Patel Pragnesh, Irani Malcolm, Graviss Edward A, Nguyen Duc T, Quigley Eamonn M M, Victor David W

机构信息

Lynda K and David M Underwood Center for Digestive Disorders, Division of Gastroenterology and Hepatology, Houston Methodist Hospital, Houston, TX, USA.

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.

出版信息

Transl Gastroenterol Hepatol. 2023 Jan 25;8:9. doi: 10.21037/tgh-21-133. eCollection 2023.

DOI:10.21037/tgh-21-133
PMID:36704652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9813646/
Abstract

BACKGROUND

Patients with cirrhosis have a high risk for morbidity and mortality in relation to abdominal surgery. Despite improvements in surgical techniques and intensive care, major abdominal surgery still remains a challenge. Major factors determining short- and long-term survival and perioperative complications in this patient population include severity of liver dysfunction, degree of portal hypertension (PHTN), and the presence of related complications such as ascites. Elective transjugular intrahepatic portosystemic shunt (TIPS) placement prior to surgery has been reported to improve perioperative outcomes, but available data is limited to case reports and small case series. We aimed to determine the impact of elective TIPS placement on perioperative outcomes after abdominal-pelvic surgeries in patients with cirrhosis.

METHODS

We performed a retrospective chart review of patients who underwent elective TIPS and compared these patients with a cohort of cirrhotic patients who underwent any abdominal surgeries without TIPS placement. The primary outcomes were mortality at 30 days and 1 year following surgery. Other post-operative outcomes compared between the two groups, included: blood loss, worsening ascites, wound leak, infections, encephalopathy, liver decompensation, and length of hospitalization.

RESULTS

Among 38 patients with cirrhosis who underwent abdominal surgery, 20 patients underwent pre-operative elective TIPS placement. Demographic characteristics of the two groups were comparable including age, gender, and body mass index (BMI). The median age was 62 years with a male predominance (62.5%). Both groups had similar etiologies of cirrhosis with hepatitis C virus (HCV) (34.2%) being most common. The most frequent indications for surgery were strangulated hernia (50%) in the TIPS group and acute cholecystitis (55.6%) in the non-TIPS group. Mean pre-TIPS hepato-venous portal gradient (HVPG) was 16.5 mmHg and mean post-TIPS HVPG was 7.0 mmHg. Mortality at 1 month was not statistically different between the groups (20% 5.6%, respectively, P=0.19). The 1-year mortality was also not statistically different between the two groups (20% 11.1%, P=0.36).

CONCLUSIONS

We found no statistically significant difference in mortality or rate of post-operative complications between patients who received pre-operative TIPS and those who did not in our age-matched cohort.

摘要

背景

肝硬化患者接受腹部手术时,发病和死亡风险较高。尽管手术技术和重症监护有所改善,但大型腹部手术仍然是一项挑战。决定该患者群体短期和长期生存以及围手术期并发症的主要因素包括肝功能障碍的严重程度、门静脉高压(PHTN)程度以及腹水等相关并发症的存在。据报道,术前择期行经颈静脉肝内门体分流术(TIPS)可改善围手术期结局,但现有数据仅限于病例报告和小型病例系列。我们旨在确定择期TIPS置入对肝硬化患者腹盆腔手术后围手术期结局的影响。

方法

我们对接受择期TIPS的患者进行了回顾性病历审查,并将这些患者与一组未行TIPS置入而接受任何腹部手术的肝硬化患者进行比较。主要结局是术后30天和1年的死亡率。两组之间比较的其他术后结局包括:失血量、腹水恶化、伤口渗漏、感染、肝性脑病、肝功能失代偿和住院时间。

结果

在38例接受腹部手术的肝硬化患者中,20例患者术前接受了择期TIPS置入。两组的人口统计学特征具有可比性,包括年龄、性别和体重指数(BMI)。中位年龄为62岁,男性占主导(62.5%)。两组肝硬化病因相似,丙型肝炎病毒(HCV)最为常见(34.2%)。TIPS组最常见的手术指征是绞窄性疝(50%),非TIPS组是急性胆囊炎(55.6%)。TIPS术前平均肝静脉门静脉梯度(HVPG)为16.5 mmHg,TIPS术后平均HVPG为7.0 mmHg。两组间1个月时的死亡率无统计学差异(分别为20%和5.6%,P = 0.19)。两组间1年死亡率也无统计学差异(20%和11.1%,P = 0.36)。

结论

在我们年龄匹配的队列中,我们发现术前接受TIPS的患者与未接受TIPS的患者在死亡率或术后并发症发生率方面无统计学显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c0/9813646/90b3c8714dd2/tgh-08-21-133-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c0/9813646/90b3c8714dd2/tgh-08-21-133-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c0/9813646/90b3c8714dd2/tgh-08-21-133-f1.jpg

相似文献

1
Impact of pre-operative transjugular intrahepatic portosystemic shunt on post-operative outcomes following non-transplant surgeries in patients with decompensated cirrhosis.术前经颈静脉肝内门体分流术对失代偿期肝硬化患者非移植手术后术后结局的影响。
Transl Gastroenterol Hepatol. 2023 Jan 25;8:9. doi: 10.21037/tgh-21-133. eCollection 2023.
2
Perioperative Transjugular Intrahepatic Portosystemic Shunt Is Associated With Decreased Postoperative Complications in Decompensated Cirrhotics Undergoing Abdominal Surgery.经颈静脉肝内门体分流术与代偿期肝硬化患者腹部手术后术后并发症减少相关。
Am Surg. 2022 Jul;88(7):1613-1620. doi: 10.1177/00031348211069784. Epub 2022 Feb 3.
3
Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery.肝硬化患者腹部手术前的择期经颈静脉肝内门体分流术
Ann Gastroenterol. 2018 May-Jun;31(3):330-337. doi: 10.20524/aog.2018.0249. Epub 2018 Mar 15.
4
Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.接受大型肝外手术的经颈静脉肝内门体分流术肝硬化患者。
J Clin Gastroenterol. 2009 Jul;43(6):574-9. doi: 10.1097/MCG.0b013e31818738ef.
5
Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study.肝硬化患者腹部手术前行经颈静脉肝内门体分流术:一项回顾性比较研究。
Can J Gastroenterol. 2006 Jun;20(6):401-4. doi: 10.1155/2006/245082.
6
Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries.对接受腹部和盆腔手术的肝硬化患者进行术前经颈静脉肝内门体分流术(TIPS)。
Surg Endosc. 2009 Jul;23(7):1594-8. doi: 10.1007/s00464-009-0405-7. Epub 2009 Mar 5.
7
Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhosis.经颈静脉肝内门体分流术作为肝硬化患者腹部手术的桥梁
J Clin Med. 2024 Apr 11;13(8):2213. doi: 10.3390/jcm13082213.
8
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.使用新型VIATORR®可控扩张支架进行控制性扩张不足可提高经颈静脉肝内门体分流术植入后的生存率。
JHEP Rep. 2021 Mar 3;3(3):100264. doi: 10.1016/j.jhepr.2021.100264. eCollection 2021 Jun.
9
A systematic review of preoperative transjugular intrahepatic portosystemic shunt prior to extrahepatic, abdominal surgery in patients with cirrhosis.肝硬化患者行肝外腹部手术前行经颈静脉肝内门体分流术的系统评价。
Saudi J Gastroenterol. 2024 Sep 1;30(5):275-282. doi: 10.4103/sjg.sjg_114_24. Epub 2024 Jun 24.
10
Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt for Portal Decompression in Patients With Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention.成功实施术前经颈静脉肝内门体分流术以对需要手术干预的炎症性肠病和肝硬化患者进行门脉减压
Crohns Colitis 360. 2024 Jun 20;6(3):otae037. doi: 10.1093/crocol/otae037. eCollection 2024 Jul.

引用本文的文献

1
Pre-Operative Assessment of Patients with Cirrhosis for Extrahepatic Surgery.肝硬化患者肝外手术的术前评估
Curr Hepatol Rep. 2025;24(1):25. doi: 10.1007/s11901-025-00697-4. Epub 2025 Jun 4.
2
Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Bridge to Bariatric Surgery in Morbidly Obese Patients with Cirrhosis and Clinically Significant Portal Hypertension.经颈静脉肝内门体分流术(TIPS):肥胖症合并肝硬化及具有临床意义的门静脉高压症患者进行减重手术的桥梁
Obes Surg. 2025 Feb;35(2):395-405. doi: 10.1007/s11695-024-07583-w. Epub 2024 Dec 29.
3
Recent TIPS increases postoperative mortality: A national cohort study.

本文引用的文献

1
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery.肝静脉压力梯度在择期行肝外手术的肝硬化患者中的预后作用。
J Hepatol. 2019 Nov;71(5):942-950. doi: 10.1016/j.jhep.2019.07.007. Epub 2019 Jul 19.
2
Original Study: Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhotic Patients.原始研究:经颈静脉肝内门体分流术作为肝硬化患者腹部手术的桥梁。
J Gastrointest Surg. 2019 Dec;23(12):2383-2390. doi: 10.1007/s11605-018-4053-x. Epub 2019 Feb 28.
3
Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery.
近期经颈静脉肝内门体分流术增加术后死亡率:一项全国队列研究。
Hepatol Commun. 2024 Nov 29;8(12). doi: 10.1097/HC9.0000000000000577. eCollection 2024 Dec 1.
4
Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhosis.经颈静脉肝内门体分流术作为肝硬化患者腹部手术的桥梁
J Clin Med. 2024 Apr 11;13(8):2213. doi: 10.3390/jcm13082213.
肝硬化患者腹部手术前的择期经颈静脉肝内门体分流术
Ann Gastroenterol. 2018 May-Jun;31(3):330-337. doi: 10.20524/aog.2018.0249. Epub 2018 Mar 15.
4
Portal Hypertension: An Underestimated Entity?门静脉高压症:一种被低估的病症?
Ann Surg. 2016 May;263(5):986-91. doi: 10.1097/SLA.0000000000001299.
5
Preoperative trans-jugular porto-systemic shunt for oncological gastric surgery in a cirrhotic patient.肝硬化患者肿瘤性胃部手术的术前经颈静脉门体分流术
World J Gastroenterol. 2015 Jan 21;21(3):997-1000. doi: 10.3748/wjg.v21.i3.997.
6
TIPS: 25 years later.小贴士:25 年后。
J Hepatol. 2013 Nov;59(5):1081-93. doi: 10.1016/j.jhep.2013.06.014. Epub 2013 Jun 25.
7
Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries.对接受腹部和盆腔手术的肝硬化患者进行术前经颈静脉肝内门体分流术(TIPS)。
Surg Endosc. 2009 Jul;23(7):1594-8. doi: 10.1007/s00464-009-0405-7. Epub 2009 Mar 5.
8
Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.接受大型肝外手术的经颈静脉肝内门体分流术肝硬化患者。
J Clin Gastroenterol. 2009 Jul;43(6):574-9. doi: 10.1097/MCG.0b013e31818738ef.
9
Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study.肝硬化患者腹部手术前行经颈静脉肝内门体分流术:一项回顾性比较研究。
Can J Gastroenterol. 2006 Jun;20(6):401-4. doi: 10.1155/2006/245082.
10
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.经颈静脉肝内门体分流术在门静脉高压症治疗中的作用。
Hepatology. 2005 Feb;41(2):386-400. doi: 10.1002/hep.20559.